DexCom, Inc.DXCMNASDAQ
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank49
5Y CAGR+25.8%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
+25.8%/yr
Long-term compound
Percentile
P49
Within normal range
vs 5Y Ago
3.2x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 33.20% |
| Q3 2025 | 14.06% |
| Q2 2025 | 59.01% |
| Q1 2025 | -29.22% |
| Q4 2024 | 24.28% |
| Q3 2024 | -3.80% |
| Q2 2024 | 56.28% |
| Q1 2024 | -53.39% |
| Q4 2023 | 5.55% |
| Q3 2023 | 60.42% |
| Q2 2023 | 171.40% |
| Q1 2023 | -62.36% |
| Q4 2022 | -14.98% |
| Q3 2022 | 91.56% |
| Q2 2022 | 86.44% |
| Q1 2022 | 6783.33% |
| Q4 2021 | -99.49% |
| Q3 2021 | 17.13% |
| Q2 2021 | 120.04% |
| Q1 2021 | -55.87% |
| Q4 2020 | 10.52% |
| Q3 2020 | 38.79% |
| Q2 2020 | 101.79% |
| Q1 2020 | -66.90% |
| Q4 2019 | 81.25% |
| Q3 2019 | 7100.00% |
| Q2 2019 | 94.44% |
| Q1 2019 | 91.25% |
| Q4 2018 | -1284.17% |
| Q3 2018 | 383.67% |
| Q2 2018 | 84.04% |
| Q1 2018 | -355.83% |
| Q4 2017 | 2500.00% |
| Q3 2017 | 96.32% |
| Q2 2017 | 66.34% |
| Q1 2017 | -562.30% |
| Q4 2016 | 67.03% |
| Q3 2016 | 7.96% |
| Q2 2016 | -4.69% |
| Q1 2016 | -1300.00% |